JNK/SAPK activity is not sufficient for anticancer therapy-induced apoptosis involving CD95-L, TRAIL and TNF-α

International Journal of Cancer

Volumn 80, Issue 3, 1999, Pages 417-424

  Herr, Ingrid ^a   Wilhelm, Dagmar ^a,b   Böhler, Thomas ^a,c   Angel, Peter ^a   Debatin, Klaus Michael ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANTINEOPLASTIC AGENT; CASPASE; CYTOKINE; DOXORUBICIN; FAS LIGAND; LIGAND; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRESS; TUMOR CELL LINE;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ARABIDOPSIS PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASPASES; DOXORUBICIN; ENZYME ACTIVATION; FATTY ACID DESATURASES; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0032941792     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990129)80:3<417::AID-IJC14>3.0.CO;2-B     Document Type: Article

References (28)

1. ANGEL, P., HATTORI, K., SMEAL, T. and KARIN, M., The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 55, 875-885 (1988).
2. CAHILL, M.A., PETER, M.E., KISCHKEL, F.C., CHINNAIYAN, A.M., DIXIT, V.M., KRAMMER, P.H. and NORDHEIM, A., CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene, 13, 2087-2096 (1996).
3. CHINNAIYAN, A.M., TEPPER, C.G., SELDIN, M.F. O'ROURKE, K., KISCHKEL, F.C., HELLBARDT, S., KRAMMER, P.H., PETER, M.E. and DIXIT, V.M., FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. biol. Chem., 271, 4961-4965 (1996).
4. CHMURA, J.S., NODZENSKKI, E., BECKETT, M.A., KUFE, D.W., QUINTANS, J. and WEICHSELBAUM, R.R., Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res., 57, 1270-1275 (1997).
5. DHEIN, J., WALCZAK, H., BÄUMLER, C., DEBATIN, K.-M. and KRAMMER, P.H., Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature (Lond.), 373, 438-441 (1995).
6. EISCHEN, C.M., KOTTKE, T.J., MARTINS, L.M., BASI, G.S., TUNG, J.S., EARNSHAW, W.C., LEIBSON, P.J. and KAUFMANN, S.H., Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood, 3, 935-943 (1997).
7. FARIS, M., KOKOT, N., LATINIS, K., KSIBHATLA, S., GREEN, D.R., KORETZKY, G.A. and NEL, A., The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol., 160, 134-144 (1998).
8. FRIESEN, C. HERR, I., KRAMMER, P.H. and DEBATIN, K.-M., Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature (Med.), 2, 574-577 (1996).
9. HERR, I., WILHELM, D., BÖHLER, T., ANGEL, P. and DEBATIN, K.-M., Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J., 16, 6200-6208 (1997).
10. HERR, I., WILHELM, D., MEYER, E., JEREMIAS, I., ANGEL, P. and DEBATIN, K.-M., JNK/SAPK activity contributes to TRAIL-induced apoptosis in human lymphoid cells. Cell Death Differentiation, (1998). (In press).
11. JEREMIAS, I., HERR, I., BÖHLER, T. and DEBATIN, K.-M., TRAIL/APO-2-ligand-induced apoptosis in human T cells. Europ. J. Immunol., 28, 143-152 (1998).
12. KASIBHATLA, S., BRUNNER, T., GENESTIER, L., ECHEVERRI, F., MAHBOUDI, A. and GREEN, D.R., DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell, 1, 543-551 (1998).
13. KRAMER, B., WIEGMANN, K. and KRONKE, M., Regulation of the human TNF promoter by the transcription factor Ets. J. biol. Chem., 270, 6577-6583 (1995).
14. LANDOWSKI, T.H., GLEASON-GUZMAN, M.C. and DALTON, W.S., Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood, 89, 1854-1861 (1997).
15. LEVERKUS, M., YAAR, M. and GILCHREST, B.A., Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp. Cell Res., 232, 255-262 (1997).
16. MICHAEL, J.M., LAVIN, M.F. and WATTERS, D.J., Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with a defective ceramide signaling. Cancer Res., 57, 3600-3605 (1997).
17. MICHEAU, O., SOLARY, E., HAMMANN, A., MARTIN, F. and DIMANCHE-BOITREL, M.-T., Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J. nat. Cancer Inst., 89, 783-789 (1997).
18. MÜLLER, M., STRAND, S., HUG, H., HEINEMANN, E.-M., WALCZAK, H., HOFMANN, W.J., STREMMEL, W., KRAMMER, P.H. and GALLE, P.R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95(APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. clin. Invest., 99, 403-413 (1997).
19. NAGATA, S., Apoptosis by death factor. Cell, 88, 355-365 (1997).
20. NATOLI, G., COSTANZO, A., IANNI, A., TEMPLETON, D.J., WOODGETT, J.R., BALSANO, C. and LEVRERO, M., Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science, 275, 200-203 (1997).
21. PENA, L.A., FUKS, Z. and KOLESNICK, R., Stress-induced apoptosis and the sphingomyelin pathway. Biochem. Pharmacol., 53, 615-621 (1997).
22. REAP, E.A., ROOF, K., MAYNOR, K., BORRERO, M., BOOKER, J. and COHEN, P.L., Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc. nat. Acad. Sci. (Wash.), 94, 5750-5755 (1997).
23. SAWAI, H., OKAZAKI, T., YAMAMOTO, H., OKANO, H., TAKEDA, Y., TASHIMA, M., SAWADA, H., OKUMA, M., ISHIKURA, H., UMEHARA, H. and DOMAE, N., Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. biol. Chem., 270, 27326-27331 (1995).
24. VILLUNGER, A., EGLE, A., KOS, M., HARTMANN, B.L., GELEY, A., KOFLER, R. and GREIL, R., Drug-induced apoptosis is associated with enhanced Fas (APO-1/CD95) ligand expression but occurs independently of Fas (APO-1/ CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res., 57, 3331-3334 (1997).
25. WILHELM, D., BENDER, K., KNEBEL, A. and ANGEL, P., The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction of pathways including JNK/SAPKs and p38 kinase by alkylating agents. Mol. cell. Biol., 17, 4792-4800 (1997).
26. XIA, Z., DICKENS, M., RAINGEAUD, J., DAVIS, R.J. and GRUENBERG, M.E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331 (1995).
27. YANG, X., KHOSRAVI-FAR, R., CHANG, H.Y. and BALTIMORE, D., Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell, 89, 1067-1076 (1997).
28. ZAGARIYA, A., MUNGRE, S., LOVIS, R., BIRRER, M., NESS, S., THIMMAPAYA, B. and POPE, R., Tumor necrosis factor alpha gene regulation: enhancement of C/EBPb-induced activation by c-Jun. Mol. cell. Biol., 18, 2815-2824 (1998).